研究業績

英文総説

(*corresponding author)(§=equally contribution)

2023

  1. Morimoto M, Maishi N, Hida K: Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression, Cancer Drug Resistance, 2023, in press
  2. Yu Li, Maishi N, Matsuda A, Hida K*: The functional network of biglycan: a new frontier in tumor progression, Proteoglycan Res, 2023(IF=0) doi: 10.1002/pgr2.11
  3. Haruhisa Watanabe , Nako Maishi, Marie Hoshi-Numahata, Mai Nishiura, Atsuko Nakanishi-Kimura, Kyoko Hida and Tadahiro Iimura*: Skeletal-Vascular Interactions in Bone Development, Homeostasis, and Pathological Destruction, Int. J. Mol. Sci. 2023, 24, 10192(IF= 6.132) doi:10.3390/ijms241310912
  4. Hida K, Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, J Med Ultrasonic, 2023(IF= 1.457 )  doi:10.1007/s10396-023-01310-1

2022

  1. Hida K, Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, J Med Ultrasonic, in press
  2. Lucas Treps, Ann Ager and Kyoko Hida K: Editorial:Tumor Vessels as Directors of the Tumor Microenvironment: New Findings, Current Challenges & Perspectives, Front. Cell Dev. Biol. Volume 10, Article 885670, March 2022
  3. Hida K, Maishi N, Takeda R, Hida Y: Metastasis, “The Roles of Tumor Endothelial Cells in Cancer Metastasis”, Exon Publications, Mar 13, 2022

2021

  1. George N.Tzanakakis, Eirini-Maria Giatagana, Aikaterini Berdiaki, Ioanna Spyridaki, Hida K, Monica Neagu, Aristidis M. Tsatsakis, and Dragana Nikitovic *: The role of IGF/IGF-IR-signaling and extracellular matrix effectors in sarcoma pathogenesis, Cancers, 13(10), 2478, 2021

2020

  1. Annan DA, Kikuchi H, Maishi N, Hida Y and Hida K*: Tumor Endothelial Cell—A Biological Tool for Translational Cancer Research, Int. J. Mol. Sci., 21, 3238, 2020

2019

  1. Maishi N, Annan DA, Kikuchi H, Hida Y and Hida K*: Tumor endothelial heterogeneity in cancer progression, Cancers, 2019, 11(10), 1511

2018

  1. *Hida K., Maishi N., Dorcas A. Annan, Hida Y.:Contribution of Tumor Endothelial Cells in Cancer Progression, Int J Mol Sci, in press
  2. *Hida K., Maishi N.:Abnormalities of tumor endothelial cells and cancer progression, Oral Sci Int, 15(1), 1-6, 2018

2017

  1. *Hida K., Maishi N.:Abnormalities of tumor endothelial cells and cancer progression, Oral Sci Int, 15(1), 1-6, 2017
  2. Maishi N., Hida K.:Tumor endothelial cells accelerate tumor metastasis, Cancer Sci, 108(10), 1921-1926, 2017
  3. *Hida K., Kikuchi H., Maishi N., Hida Y:ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy, Cancer Lett, 400, 305-310, 2017

2016

  1. *Hida K., Maishi N., Torii C., Hida Y.:Tumor Angiogenesis—Characteristics of Tumor Endothelial Cells, Int J Clin Oncol, 21(2),206-212,2016
  2. *Hida K., Maishi N., Sakurai Y., Hida Y., Harashima H.:Heterogeneity of tumor endothelial cells and drug delivery, Adv Drug Deliv Rev99(Pt B), 140-147, 2016

2013

  1. *Hida K., Ohga N., Akiyama K., Maishi N., Hida Y.:Heterogeneity of tumor endothelial cells, Cancer Sci, 104(11), 1391-1395, 2013
  2. *Hida K., Akiyama K., Ohga N., Maishi N., Hida Y.: Tumor endothelial cells acquire drug resistance in a tumor microenvironment, J Biochem,153(3), 243-249, 2013

2011

  1. *Hida K., Kawamoto T., Ohga N., Akiyama K., Hida Y., Shindoh M.: Altered angiogenesis in the tumor microenvironment, Pathol Int, 61(11), 630-637, 2011

2010

  1. Higashino F., *Hida K., Kitamura T., Ohga N., Shindoh M.:Aberrant control of transcription and transportation of oncogenic mRNA in carcinogenesis,Oral Sci Int, 7(1), 11-18, 2010
  2. *Hida K., Ohga N., Kurosu T.,Totsuka Y.andShindoh M.: Crosstalk between blood vessels and tumor microenvironment,Oral Sci Int, 7(1), 1-10, 2010

2009

  1. *Hida K., Ohga N.,Hida Y. and Shindoh M.: Significance of Antiangiogenic Therapy in Head and Neck Cancer-Heterogeneity of Tumor Endothelium. Jpn Dent Sci Review, 46, 26-32, 2009

2008年以前

  1. *Hida K., Hida Y. an Shindoh M.: Understanding Abnormality of Tumor Endothelial Cells to Develop Ideal Anti-angiogenic Therapies. Cancer Sci. 99 (3), 459-466, 2008
  2. *Hida K.. and Klgsbrun M.: A new perspective on tumor endothelial cells; Unexpected Chromosome and centrosome abnormalities. Cancer Res, 65 (7), 1-4, 2005